You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

43 search results for: mechanism of disease

Type 2 Inflammation and Chronic Pruritus in AD and PN
expert video

Type 2 Inflammation and Chronic Pruritus in AD and PN

Dermatology
Highlights from the ADVENT symposium at AAD 2023 on the shared and unique roles of type 2 inflammation in atopic dermatitis and prurigo nodularis.
View more
Neuroimmune Axis and Pruritus in PN
expert video

Neuroimmune Axis and Pruritus in PN

Dermatology
Changes in nerve density and dysfunction of the neuroimmune axis drive pruritus in prurigo nodularis – Highlight from the ADVENT symposium at AAD 2023.
View more
Contributions <b>of</b> Type 2 Cytokines to Chronic Pruritus in AD, PN, and CSU
expert video

Contributions of Type 2 Cytokines to Chronic Pruritus in AD, PN, and CSU

Dermatology
Dr. Elmariah introduces the multiple roles of type 2 cytokines in chronic itch.
View more
Under the Skin: Considerations for Atopic Dermatitis and Prurigo Nodularis in Clinical Practice
expert video

Under the Skin: Considerations for Atopic Dermatitis and Prurigo Nodularis in Clinical Practice

Dermatology
In this ADVENT symposium at the 2024 Diversity in Dermatology conference, experts Dr(s) Sarina Elmariah and Mona Shahriari engage in a dynamic discussion on diagnostic considerations for atopic dermatitis and prurigo nodularis and how clinical signs and itch in these diseases are impacted by type 2 inflammation.
View more
Effect <b>of</b> Type 2 Inflammation on Skin Barrier Function in AD​
interactivity

Effect of Type 2 Inflammation on Skin Barrier Function in AD​

Dermatology
Gain insights on how type 2 inflammation affects different aspects of skin barrier function – an interactive educational tool.
View more
Atopic Dermatitis as a Risk Factor for Food Allergy
expert video

Atopic Dermatitis as a Risk Factor for Food Allergy

Type 2 Inflammation
Discover how atopic dermatitis can be a risk for the development of food allergies.
View more
IRS-ISIAN 2024 | The Importance <b>of</b> Understanding Smell Loss and Congestion in CRSwNP
expert video

IRS-ISIAN 2024 | The Importance of Understanding Smell Loss and Congestion in CRSwNP

Rhinology
Prof. Joaquim Mullol presents on the proposed mechanisms of smell loss and nasal congestion in CRSwNP.
View more
Skin Dyspigmentation In Prurigo Nodularis (PN)
interactivity

Skin Dyspigmentation In Prurigo Nodularis (PN)

Dermatology
This infographic illustrates the clinical manifestations, pathophysiology and impact on patients of skin dyspigmentation in Prurigo Nodularis.
View more
Neuroimmune Axis Dysregulation and Type 2 Inflammation: Shared Roles in AD, PN, and CSU
expert video

Neuroimmune Axis Dysregulation and Type 2 Inflammation: Shared Roles in AD, PN, and CSU

Dermatology
Exploration of the shared type 2 inflammation and neuroimmune axis dysfunction in AD, PN, and CSU leading to itch.
View more
AD Static Infographic
Infographic

AD Static Infographic

Dermatology
Review atopic dermatitis in this infographic
View more
OCS Awareness Infographic
Infographic

OCS Awareness Infographic

Pulmonology
Review this infographic on OCS Awareness
View more
Esophageal Dilation Does Not Impact Underlying Inflammation in EoE
expert video

Esophageal Dilation Does Not Impact Underlying Inflammation in EoE

Gastroenterology
Dr. Evan Dellon discusses why esophageal dilation improves symptoms but does not address the underlying histology or disease activity in EoE.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi | Regeneron Logo

© 2024 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ArgentinaChange country/region